Guangdong Biolight Meditech Co., Ltd. (300246.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Guangdong Biolight Meditech Co., Ltd.
—
Guangdong Biolight Meditech Co., Ltd. is led by CEO Jinyuan Yan, employs 1,335 people, headquartered in Zhuhai, CN, publicly traded since 2011.
Guangdong Biolight Meditech Co., Ltd. (300246.SZ) stock trades at $12.64 with a market capitalization of $3.69B. The stock is valued at a negative price-to-earnings (P/E) ratio of -38.18, reflecting a net loss over the last twelve months, price-to-book of 3.30, price-to-sales of 3.53. Over the past 52 weeks the stock has ranged between $7.67 and $21.98, and currently trades 42.5% below its 52-week high. It pays a dividend yielding 0.35%.
On profitability, Guangdong Biolight Meditech Co., Ltd. generates a return on equity (ROE) of -4.76% (negative, reflecting a net loss), an operating margin of -13.29%, a net profit margin of -6.32%.
Official website: www.blt.com.cn
Guangdong Biolight Meditech Co., Ltd. (300246.SZ) — frequently asked questions
What is Guangdong Biolight Meditech Co., Ltd. (300246.SZ) stock price today?
Guangdong Biolight Meditech Co., Ltd. (300246.SZ) is currently trading at $12.64, down 2.39% today.
What is 300246.SZ P/E ratio?
Guangdong Biolight Meditech Co., Ltd.'s P/E ratio is -38.18. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is 300246.SZ return on equity (ROE)?
Guangdong Biolight Meditech Co., Ltd.'s return on equity (ROE) is -4.76%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Guangdong Biolight Meditech Co., Ltd.'s market cap?
Guangdong Biolight Meditech Co., Ltd. has a market capitalization of $3.69B.
Does 300246.SZ pay a dividend?
Yes. Guangdong Biolight Meditech Co., Ltd. currently yields 0.35%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 300246.SZ carry?
Guangdong Biolight Meditech Co., Ltd. has a debt-to-equity ratio of 0.55. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 300246.SZ's profit margin?
Guangdong Biolight Meditech Co., Ltd. reports a net profit margin of -6.32% — the share of revenue left after every cost, including tax and interest.
What sector is 300246.SZ in?
Guangdong Biolight Meditech Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 300246.SZ listed on?
Guangdong Biolight Meditech Co., Ltd. trades on SHZ under the ticker 300246.SZ.
What is 300246.SZ's 52-week range?
Over the last year Guangdong Biolight Meditech Co., Ltd. has traded between $7.67 and $21.98.
Related — Stocks
Popular Stocks
Screens 300246.SZ currently matches
On the figures above, Guangdong Biolight Meditech Co., Ltd. passes the filters for 4 of our ready-made screens, among them Stocks Under $100, Stocks Under $50, Mid Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.